First Command Bank’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-285
Closed -$10K 426
2018
Q3
$10K Hold
285
﹤0.01% 329
2018
Q2
$8K Hold
285
﹤0.01% 354
2018
Q1
$7.34K Buy
+285
New +$7.72K ﹤0.01% 369

Other funds holding ARKG

First Command Bank's ARKG Position: Q4 2018 in Review

First Command Bank sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2018, closing a stake of 285 shares — an estimated $10K sold.

First Command Bank first reported a position in ARKG in Q1 2018 and held it in 3 quarters. The position peaked at $10K in Q3 2018. 58 funds tracked by Wall St. Rank hold ARKG as of Q4 2018.

  • First Command Bank reported no remaining ARK Genomic Revolution ETF position as of Q4 2018 after selling out during the quarter.
  • First Command Bank sold 285 ARK Genomic Revolution ETF shares in Q4 2018, an estimated $10K.
  • First Command Bank first reported a position in ARK Genomic Revolution ETF in Q1 2018 and held it in 3 quarters.
  • First Command Bank's ARK Genomic Revolution ETF position peaked at $10K in Q3 2018.
  • 58 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2018.

Based on First Command Bank's 13F filing for Q4 2018, filed 18 Jan 2019.